Enzolytics IPF Immune™ is the Perfect Choice for People With Weakened Immune Systems

The body’s immune system is constantly under attack.

Even before COVID-19, infections, such as the regular flu virus, weakened the immune system. Lifestyle choices, such as an inadequate diet, smoking, and alcohol consumption, also affect the immune system.

A new immune modulator, Enzolytics IPF Immune™, will soon be available to American consumers.

“Enzolytics IPF Immune™ strengthens the body’s immune system,” said Charles S. Cotropia, CEO of Enzolytics, Inc., a Texas biotech company. “COVID-19 made everyone aware and concerned about their immune system.”

Since the pandemic started, sales for immune booster supplements skyrocketed. The global immune health supplements market is projected to grow from $20.18 billion in 2021 to $31.50 billion in 2028

“Now, consumers have a science-backed immune modulator to keep their bodies operating optimally,” he added.

“Our immune modulator helps fortify the immune system against infections,” said Harry Zhabilov, the Company CSO. “Enzolytics’ research and development team spent more than a decade developing Enzolytics IPF Immune™.”

Enzolytics IPF Immune™ is a liquid nutritional supplement that acts to strengthen the body’s natural defenses,” Mr. Zhabilov said.

Enzolytics IPF Immune™ is gluten-free, and an easy-to-use liquid that is taken orally for two consecutive days per week for eight consecutive weeks.

“You can take Enzolytics IPF Immune™ to give your immune system a boost to ward off many infections that your body is confronted with year-round,” he added.

For more information, email [email protected] or visit enzolytics.com.

Disclaimer: The statements made regarding these products have not been evaluated by the Food and Drug Administration. This press release is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please check with your doctor. The news site hosting this press release is not associated with Enzolytics, Inc. It is merely publishing a press release announcement submitted by a company, without any stated or implied endorsement of the product or service.

Company Contact:

Enzolytics, Inc.

2000 North Central Expressway

Plano, TX 75074

And

Research Center

Enzolytics, Inc.

Texas A&M University

Institute for Preclinical Studies

College Station, TX 77843-44

SOURCE: Enzolytics, Inc.

About Enzolytics, Inc.

Enzolytics Inc. is a Texas-based biotechnology company that focuses on therapeutics to treat numerous human health medical conditions. In addition to Enzolytics IPF Immune™, which will be on the U.S. market soon, the Company is developing other therapeutics for treating multiple infectious diseases, including monoclonal antibodies for treating COVID-19 and HIV, and anti-cancer therapeutics.

Press Contact

Name: Robert Grant Phone: 5615440719 Email: Contact Us Website: https://inhealthmedia.com/